NM_001503.4:c.2294A>G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001503.4(GPLD1):c.2294A>G(p.Glu765Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000217 in 1,614,002 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001503.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GPLD1 | NM_001503.4 | c.2294A>G | p.Glu765Gly | missense_variant | Exon 22 of 25 | ENST00000230036.2 | NP_001494.2 | |
GPLD1 | XM_017010753.3 | c.2324A>G | p.Glu775Gly | missense_variant | Exon 23 of 26 | XP_016866242.1 | ||
GPLD1 | XM_047418657.1 | c.1805A>G | p.Glu602Gly | missense_variant | Exon 17 of 20 | XP_047274613.1 | ||
GPLD1 | XR_007059240.1 | n.2601A>G | non_coding_transcript_exon_variant | Exon 23 of 27 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152216Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251362Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135862
GnomAD4 exome AF: 0.0000233 AC: 34AN: 1461786Hom.: 0 Cov.: 31 AF XY: 0.0000275 AC XY: 20AN XY: 727202
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152216Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74358
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.2294A>G (p.E765G) alteration is located in exon 22 (coding exon 22) of the GPLD1 gene. This alteration results from a A to G substitution at nucleotide position 2294, causing the glutamic acid (E) at amino acid position 765 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at